BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 32790648)

  • 1. Boosting NAD level suppresses inflammatory activation of PBMCs in heart failure.
    Zhou B; Wang DD; Qiu Y; Airhart S; Liu Y; Stempien-Otero A; O'Brien KD; Tian R
    J Clin Invest; 2020 Nov; 130(11):6054-6063. PubMed ID: 32790648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial respiratory dysfunctions of blood mononuclear cells link with cardiac disturbance in patients with early-stage heart failure.
    Li P; Wang B; Sun F; Li Y; Li Q; Lang H; Zhao Z; Gao P; Zhao Y; Shang Q; Liu D; Zhu Z
    Sci Rep; 2015 May; 5():10229. PubMed ID: 26018291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide riboside does not alter mitochondrial respiration, content or morphology in skeletal muscle from obese and insulin-resistant men.
    Dollerup OL; Chubanava S; Agerholm M; Søndergård SD; Altıntaş A; Møller AB; Høyer KF; Ringgaard S; Stødkilde-Jørgensen H; Lavery GG; Barrès R; Larsen S; Prats C; Jessen N; Treebak JT
    J Physiol; 2020 Feb; 598(4):731-754. PubMed ID: 31710095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinamide Riboside, an NAD + Precursor, Protects Against Cardiac Mitochondrial Dysfunction in Fetal Guinea Pigs Exposed to Gestational Hypoxia.
    Thompson LP; Song H; Hartnett J
    Reprod Sci; 2024 Apr; 31(4):975-986. PubMed ID: 37957471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Tolerability of Nicotinamide Riboside in Heart Failure With Reduced Ejection Fraction.
    Wang DD; Airhart SE; Zhou B; Shireman LM; Jiang S; Melendez Rodriguez C; Kirkpatrick JN; Shen DD; Tian R; O'Brien KD
    JACC Basic Transl Sci; 2022 Dec; 7(12):1183-1196. PubMed ID: 36644285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinamide riboside supplementation exerts an anti-obesity effect and prevents inflammation and fibrosis in white adipose tissue of female diet-induced obesity mice.
    Kim MB; Pham TX; vanLuling M; Kostour V; Kang H; Corvino O; Jang H; Odell W; Bae M; Park YK; Lee JY
    J Nutr Biochem; 2022 Sep; 107():109058. PubMed ID: 35643283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans.
    Trammell SA; Schmidt MS; Weidemann BJ; Redpath P; Jaksch F; Dellinger RW; Li Z; Abel ED; Migaud ME; Brenner C
    Nat Commun; 2016 Oct; 7():12948. PubMed ID: 27721479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide-induced microglial and astrocytic neuroinflammation by increasing NAD
    Roboon J; Hattori T; Ishii H; Takarada-Iemata M; Nguyen DT; Heer CD; O'Meally D; Brenner C; Yamamoto Y; Okamoto H; Higashida H; Hori O
    J Neurochem; 2021 Jul; 158(2):311-327. PubMed ID: 33871064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans.
    Remie CME; Roumans KHM; Moonen MPB; Connell NJ; Havekes B; Mevenkamp J; Lindeboom L; de Wit VHW; van de Weijer T; Aarts SABM; Lutgens E; Schomakers BV; Elfrink HL; Zapata-Pérez R; Houtkooper RH; Auwerx J; Hoeks J; Schrauwen-Hinderling VB; Phielix E; Schrauwen P
    Am J Clin Nutr; 2020 Aug; 112(2):413-426. PubMed ID: 32320006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment.
    Orr ME; Kotkowski E; Ramirez P; Bair-Kelps D; Liu Q; Brenner C; Schmidt MS; Fox PT; Larbi A; Tan C; Wong G; Gelfond J; Frost B; Espinoza S; Musi N; Powers B
    Geroscience; 2024 Feb; 46(1):665-682. PubMed ID: 37994989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers.
    Airhart SE; Shireman LM; Risler LJ; Anderson GD; Nagana Gowda GA; Raftery D; Tian R; Shen DD; O'Brien KD
    PLoS One; 2017; 12(12):e0186459. PubMed ID: 29211728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of NAD+ boosting on kidney ischemia-reperfusion injury.
    Morevati M; Egstrand S; Nordholm A; Mace ML; Andersen CB; Salmani R; Olgaard K; Lewin E
    PLoS One; 2021; 16(6):e0252554. PubMed ID: 34061900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAD
    Tong D; Schiattarella GG; Jiang N; Altamirano F; Szweda PA; Elnwasany A; Lee DI; Yoo H; Kass DA; Szweda LI; Lavandero S; Verdin E; Gillette TG; Hill JA
    Circ Res; 2021 May; 128(11):1629-1641. PubMed ID: 33882692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting sirtuin activity with nicotinamide riboside reduces neuroinflammation in a GWI mouse model.
    Joshi U; Evans JE; Pearson A; Saltiel N; Cseresznye A; Darcey T; Ojo J; Keegan AP; Oberlin S; Mouzon B; Paris D; Klimas N; Sullivan K; Mullan M; Crawford F; Abdullah L
    Neurotoxicology; 2020 Jul; 79():84-94. PubMed ID: 32343995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical Characterization of Pharmacologic NAD
    Perez-Sanchez C; Escudero-Contreras A; Cerdó T; Sánchez-Mendoza LM; Llamas-Urbano A; la Rosa IA; Pérez-Rodriguez M; Muñoz-Barrera L; Del Carmen Abalos-Aguilera M; Barbarroja N; Calvo J; Ortega-Castro R; Ruiz-Vilchez D; Moreno JA; Burón MI; González-Reyes JA; Collantes-Estevez E; Lopez-Pedrera C; Villalba JM
    Arthritis Rheumatol; 2023 Oct; 75(10):1749-1761. PubMed ID: 37094367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinamide riboside, an NAD+ precursor, attenuates the development of liver fibrosis in a diet-induced mouse model of liver fibrosis.
    Pham TX; Bae M; Kim MB; Lee Y; Hu S; Kang H; Park YK; Lee JY
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2451-2463. PubMed ID: 31195117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinamide riboside attenuates alcohol induced liver injuries via activation of SirT1/PGC-1α/mitochondrial biosynthesis pathway.
    Wang S; Wan T; Ye M; Qiu Y; Pei L; Jiang R; Pang N; Huang Y; Liang B; Ling W; Lin X; Zhang Z; Yang L
    Redox Biol; 2018 Jul; 17():89-98. PubMed ID: 29679894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAD
    Crisol BM; Veiga CB; Braga RR; Lenhare L; Baptista IL; Gaspar RC; Muñoz VR; Cordeiro AV; da Silva ASR; Cintra DE; Moura LP; Pauli JR; Ropelle ER
    Eur J Nutr; 2020 Sep; 59(6):2427-2437. PubMed ID: 31494696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of the nicotinamide riboside kinase NAD
    Doig CL; Zielinska AE; Fletcher RS; Oakey LA; Elhassan YS; Garten A; Cartwright D; Heising S; Alsheri A; Watson DG; Prehn C; Adamski J; Tennant DA; Lavery GG
    Skelet Muscle; 2020 Feb; 10(1):5. PubMed ID: 32075690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity.
    Cantó C; Houtkooper RH; Pirinen E; Youn DY; Oosterveer MH; Cen Y; Fernandez-Marcos PJ; Yamamoto H; Andreux PA; Cettour-Rose P; Gademann K; Rinsch C; Schoonjans K; Sauve AA; Auwerx J
    Cell Metab; 2012 Jun; 15(6):838-47. PubMed ID: 22682224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.